Tissue Engineering Conjunctiva Transplantation and Conjunctival Sac Formation for the Treatment of Pterygium and Atretoblepharia
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- The epithelial defect size of the transplanted tissue engineering conjunctiva
研究概览
简要总结
The purpose of this study is to determine whether tissue engineering conjunctiva is effective in the treatment of pterygium and atretoblepharia.
详细描述
The most important area for research on the pterygium are the recurrence occurred after operation. Now the best way to prevent the recurrence is autologous conjunctival stem cell transplantation, but this way of operation can cause lack of conjunctiva and conjunctival scar, even may effect the later glaucoma surgery. For the atretoblepharia patients, amniotic membrane transplantation and autologous oral mucosa transplantation can not make effect to alleviate it. In this pilot project, investigators would like to study the effect of tissue engineering conjunctiva transplantation in the treatment of pterygium and tissue engineering conjunctiva transplantation combined with conjunctiva sac formation for the treatment of atretoblepharia. This will allow us to determine if useful data can be obtained, and if so, lead to further studies in various conjunctiva loss caused by trauma, infections, and so on.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Primary and recurrent pterygium patients,atretoblepharia patients
- •Voluntarily signed informed consent
- •No surgery and anesthesia contraindications.
排除标准
- •The patients combined systemic diseases
- •Reject study and follow visit
- •Patients don't accept the tissue engineering conjunctiva
- •Cannot tolerate surgery or anesthesia
研究组 & 干预措施
Optical Coherence tomography
干预措施: Tissue engineering conjunctiva transplantation (Procedure)
结局指标
主要结局
The epithelial defect size of the transplanted tissue engineering conjunctiva
时间窗: the 7 days after operation
次要结局
未报告次要终点
